$0.55
0.0373[7.28%]
At close: Apr 24
$0.55
0[0.00%]
After Hours: 7:53PM EDT
Purple Biotech
(NASDAQ:PPBT)Latest News for Purple Biotech Stock (NASDAQ:PPBT)
Purple Biotech Stock (NASDAQ: PPBT)
Categories: All
Monday, April 22, 2024
Thursday, March 14, 2024
Thursday, March 07, 2024
Tuesday, March 05, 2024
Tuesday, February 27, 2024
Thursday, February 01, 2024
Wednesday, January 10, 2024
Thursday, December 14, 2023
Monday, December 11, 2023
Tuesday, November 21, 2023
- HC Wainwright & Co. Maintains Buy on Purple Biotech, Raises Price Target to $10Benzinga Newsdesk - Nov 21, 2023, 1:45PM
- Purple Biotech: Q3 Earnings InsightsBenzinga Insights - Nov 21, 2023, 7:00AM
- Purple Biotech Q3 EPS $(0.23), Inline; $15.9M In Cash, Cash Equivalents And Short-term Deposits. In October 2023 The Company Raised An Additional Gross Amount Of $5M Extended The Cash Runway To The Second Half Of 2025Benzinga Newsdesk - Nov 21, 2023, 6:56AM
Tuesday, October 17, 2023
Friday, October 13, 2023
Friday, October 06, 2023
Tuesday, October 03, 2023
Thursday, September 21, 2023
Thursday, August 31, 2023
Wednesday, August 30, 2023
Tuesday, August 22, 2023
Monday, July 31, 2023
Thursday, July 27, 2023
Tuesday, July 25, 2023
Monday, July 24, 2023
Friday, July 21, 2023
Wednesday, July 12, 2023
Tuesday, July 11, 2023
Wednesday, May 17, 2023
Tuesday, May 16, 2023
Wednesday, April 19, 2023
Thursday, March 16, 2023
Tuesday, February 14, 2023
Thursday, February 09, 2023
Wednesday, February 08, 2023
Wednesday, February 01, 2023
Thursday, December 08, 2022
Wednesday, December 07, 2022
Tuesday, November 08, 2022
Wednesday, November 02, 2022
Monday, October 17, 2022
- Purple Biotech's Assets Are First In Class For Solid Tumor Treatment, Analyst SaysVandana Singh - Oct 17, 2022, 1:30PM
- Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2022Benzinga Insights - Oct 17, 2022, 10:02AM
- HC Wainwright & Co. Initiates Coverage On Purple Biotech with Buy Rating, Announces Price Target of $7Benzinga Newsdesk - Oct 17, 2022, 6:17AM